 SARASOTA, Fla., April 12, 2021 PRNewswire -- INVO Bioscience, Inc. NASDAQ: INVO, a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell, the worlds only in vivo Intravaginal Culture System, announced today that Steve Shum, CEO of INVO Bioscience, will present at Tribe Publics Webinar Presentation and QA Event titled Democratizing Infertility - A Severely Underserved Global Market. 